These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33756436)

  • 1. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
    Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
    Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
    Zhang X; Liu J; Ye J
    Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
    Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
    Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms.
    Riffi R; Boughrara W; Chentouf A; Ilias W; Brahim NMT; Berrebbah AA; Belhoucine F
    CNS Neurol Disord Drug Targets; 2024; 23(12):1463-1473. PubMed ID: 38859787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis.
    Fan YX; Zhang Z; Meng JR; Yin SJ; Wang P; Zhou T; Huang YH; Meng R; He GH
    Epilepsy Res; 2021 Nov; 177():106785. PubMed ID: 34653781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
    Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y
    Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis.
    Zhao GX; Shen ML; Zhang Z; Wang P; Xie CX; He GH
    Int J Clin Pharm; 2019 Dec; 41(6):1414-1428. PubMed ID: 31650507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.
    He XJ; Jian LY; He XL; Tang M; Wu Y; Xu YY; Sun XJ; Zhao LM
    Epilepsia; 2014 Aug; 55(8):1301-6. PubMed ID: 24861996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
    Bao Y; Liu X; Xiao Z
    Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
    Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
    PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up.
    Zhou BT; Zhou QH; Yin JY; Li GL; Qu J; Xu XJ; Liu D; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Jul; 18(7):566-72. PubMed ID: 22591328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
    Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
    Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
    Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
    Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy].
    Huang J; Qian Z; Chen H; Huang Q; Huang L; Liu G; Tang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Mar; 36(3):271-274. PubMed ID: 30835363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients.
    Wang P; Zhou Q; Sheng Y; Tang B; Liu Z; Zhou B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 May; 39(5):433-41. PubMed ID: 24921390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population.
    Zhou BT; Zhou QH; Yin JY; Li GL; Xu XJ; Qu J; Liu D; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):379-84. PubMed ID: 22292851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
    Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
    Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
    Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
    Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.